Gene–environment interactions in sporadic Parkinson's disease
暂无分享,去创建一个
[1] S. Nanko,et al. No association between Parkinson's disease and monoamine oxidase A and B gene polymorphisms , 1996, Neuroscience Letters.
[2] Houeto Jean-Luc. [Parkinson's disease]. , 2022, La Revue du praticien.
[3] P. Rotwein,et al. Human tyrosine hydroxylase and insulin genes are contiguous on chromosome 11. , 1988, Nucleic acids research.
[4] M. Polymeropoulos,et al. Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients , 2000, Neuroreport.
[5] W. Rocca. Prevalence of Parkinson's disease in China , 2005, The Lancet Neurology.
[6] Yi-ping Fu,et al. Pesticide exposure on southwestern Taiwanese with MnSOD and NQO1 polymorphisms is associated with increased risk of Parkinson's disease. , 2007, Clinica chimica acta; international journal of clinical chemistry.
[7] A. Quattrone,et al. The dopamine D2 receptor gene is a susceptibility locus for Parkinson's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.
[8] M. Delong,et al. Functional neuroanatomy of the basal ganglia in Parkinson's disease. , 2003, Advances in neurology.
[9] Y Ben-Shlomo,et al. Cross sectional prevalence survey of idiopathic Parkinson's disease and parkinsonism in London , 2000, BMJ : British Medical Journal.
[10] Barry Halliwell,et al. Failure of the ubiquitin–proteasome system in Parkinson's disease , 2001, Nature Reviews Neuroscience.
[11] D. Sibley,et al. Functional Analysis of the Human D2 Dopamine Receptor Missense Variants* , 1996, The Journal of Biological Chemistry.
[12] A. Whitehead,et al. Frequency of the apolipoprotein E epsilon 4 allele in a case-control study of early onset Parkinson's disease. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[13] E. Schwartz,et al. Paraoxonase 1 Met–Leu 54 polymorphism is associated with Parkinson’s disease , 2001, Journal of the Neurological Sciences.
[14] L. Bertilsson,et al. LOW FREQUENCY OF SLOW DEBRISOQUINE HYDROXYLATION IN A NATIVE CHINESE POPULATION , 1987, The Lancet.
[15] U. Muthane,et al. Experiences of Parkinson's disease in India , 2002, Lancet Neurology.
[16] A. Hofman,et al. CYP2D6 polymorphism in Parkinson's disease: The Rotterdam study , 2001, Movement disorders : official journal of the Movement Disorder Society.
[17] I. Craig,et al. Dinucleotide repeat polymorphism at the MAOA locus. , 1991, Nucleic acids research.
[18] Z. Liu,et al. No association between paraoxonase 1 (PON1) gene polymorphisms and susceptibility to Parkinson's disease in a Chinese population , 2000, Movement disorders : official journal of the Movement Disorder Society.
[19] H. Cohen,et al. The anxiolytic effect of chronic inositol depends on the baseline level of anxiety , 2000, Journal of Neural Transmission.
[20] M. Oda,et al. Genetic studies in Parkinson's disease with an α-synuclein/NACP gene polymorphism in Japan , 2001, Neuroscience Letters.
[21] D. L. Le Couteur,et al. Paraoxonase polymorphisms, pesticide exposure and Parkinson's disease in a Caucasian population , 2000, Journal of Neural Transmission.
[22] Yifu Deng,et al. Further evidence that interactions between CYP2D6 and pesticide exposure increase risk for Parkinson's disease , 2004, Annals of neurology.
[23] E K Perry,et al. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. , 1997, Pharmacogenetics.
[24] C. Négre. [Treatment of Parkinson's disease]. , 1986, Soins; la revue de reference infirmiere.
[25] S. Ho,et al. G/A1947 polymorphism in catechol‐O‐methyltransferase (COMT) gene in Parkinson's disease , 1997, Movement disorders : official journal of the Movement Disorder Society.
[26] C. Morris,et al. Parkinson's disease is not associated with the combined α‐synuclein/apolipoprotein E susceptibility genotype , 2001, Annals of neurology.
[27] M. Farrer,et al. Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson’s disease , 1999, Neurology.
[28] G. Opala,et al. Catechol-O-Methyltransferase and Monoamine Oxidase B Genes and Susceptibility to Sporadic Parkinson’s Disease in a Polish Population , 2005, European Neurology.
[29] H. Checkoway,et al. A pilot study of occupational and environmental risk factors for Parkinson's disease. , 1991, Neurotoxicology.
[30] Christophe Tzourio,et al. CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease , 2004, Annals of neurology.
[31] A. Lang,et al. Parkinson's disease. First of two parts. , 1998, The New England journal of medicine.
[32] C. Goetz,et al. Genetic variability of the CYP 2D6 gene is not a risk factor for sporadic Parkinson's disease , 1996, Annals of neurology.
[33] W. T. Hung,et al. Genetic and environmental risk factors for Parkinson’s disease in a Chinese population , 1998, Journal of neurology, neurosurgery, and psychiatry.
[34] Dayu Lin,et al. Genetic study of apolipoprotein E gene, alpha-1 antichymotrypsin gene in sporadic Parkinson disease. , 2002, American journal of medical genetics.
[35] M G Spillantini,et al. Alpha-synuclein in Lewy bodies. , 1997, Nature.
[36] D. Schaid,et al. Case‐control study of debrisoquine 4‐hydroxylase, n‐acetyltransferase 2, and apolipoprotein e gene polymorphisms in Parkinson's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.
[37] A. Quattrone,et al. NACP-REP1 polymorphism is not involved in Parkinson's disease: a case-control study in a population sample from southern Italy , 2003, Neuroscience Letters.
[38] M. Oda,et al. Genetic studies in Parkinson's disease with an alpha-synuclein/NACP gene polymorphism in Japan. , 2001, Neuroscience letters.
[39] J. Jankovic,et al. Variability and validity of polymorphism association studies in Parkinson’s disease , 2000, Neurology.
[40] Josemir W Sander,et al. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. , 2000, Brain : a journal of neurology.
[41] V. Hachinski,et al. Environmental Exposures in Elderly Canadians With Parkinson’s Disease , 1995, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[42] A. Kuwano,et al. Association analysis of a polymorphism of the monoamine oxidase B gene with Parkinson's disease in a Japanese population. , 1995, American journal of medical genetics.
[43] D. Buchanan,et al. Variations in the monoamine oxidase B lpar;MAOB) gene are associated with Parkinson's disease , 1999, Movement disorders : official journal of the Movement Disorder Society.
[44] B. Müller-Myhsok,et al. The CYP2D6B allele is not overrepresented in a population of German patients with idiopathic Parkinson's disease. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[45] S. Nanko,et al. Association study of structural mutations of the tyrosine hydroxylase gene with schizophrenia and Parkinson's disease. , 1998, American journal of medical genetics.
[46] Hagai Bergman,et al. Stepping out of the box: information processing in the neural networks of the basal ganglia , 2001, Current Opinion in Neurobiology.
[47] R. Krüger,et al. Increased susceptibility to sporadic Parkinson's disease by a certain combined α‐synuclein/apolipoprotein E genotype , 1999, Annals of neurology.
[48] G. Savettieri,et al. Lack of association between ubiquitin carboxy-terminal hydrolase L1 gene polymorphism and PD , 2001, Neurology.
[49] R. Zivadinov,et al. Familial and environmental risk factors in Parkinson's disease: a case–control study in north‐east Italy , 2002, Acta neurologica Scandinavica.
[50] S. Sawcer,et al. The genetic basis of Parkinson's disease , 2002, Journal of neurology, neurosurgery, and psychiatry.
[51] A. Chiò,et al. Prevalence of Parkinson's disease in northwestern italy: Comparison of tracer methodology and clinical ascertainment of cases , 1998, Movement disorders : official journal of the Movement Disorder Society.
[52] C. Markham,et al. Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease , 1994, Movement disorders : official journal of the Movement Disorder Society.
[53] C. Brayne,et al. The Epidemiology of Parkinson’s Disease in an Australian Population , 1998, Neuroepidemiology.
[54] M. Anvret,et al. Further evidence for an association of the Paraoxonase 1 (PON1) Met‐54 allele with Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.
[55] M. Druet‐Cabanac,et al. Parkinson’s Disease and Environmental Factors , 2000, Neuroepidemiology.
[56] P. Jenner. Parkinson's disease, pesticides and mitochondrial dysfunction , 2001, Trends in Neurosciences.
[57] M. Druet‐Cabanac,et al. Parkinson's disease and environmental factors. Matched case-control study in the Limousin region, France. , 2000, Neuroepidemiology.
[58] E. Love,et al. Parkinson's disease and exposure to agricultural work and pesticide chemicals , 1992, Neurology.
[59] G. Jarvik,et al. Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. , 2001, American journal of human genetics.
[60] E. Shahar,et al. Extra-pyramidal parkinsonism complicating organophosphate insecticide poisoning. , 2001, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[61] O. Axelson,et al. Age-standardized incidence and prevalence of Parkinson's disease in a Swedish community. , 1996, Journal of clinical epidemiology.
[62] T. Dawson,et al. Oxidative Stress and Genetics in the Pathogenesis of Parkinson's Disease , 2000, Neurobiology of Disease.
[63] V. Lee,et al. A new link between pesticides and Parkinson's disease , 2000, Nature Neuroscience.
[64] P. Taba,et al. Prevalence of Parkinson's disease in Estonia , 2002, Acta neurologica Scandinavica.
[65] R. Wu,et al. Pesticides exposure and genetic polymorphism of paraoxonase in the susceptibility of Parkinson's disease. , 2005, Acta neurologica Taiwanica.
[66] S E Ide,et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.
[67] A. Hofman,et al. N-acetyltransferase-2 polymorphism in Parkinson’s disease: the Rotterdam study , 1999, Journal of neurology, neurosurgery, and psychiatry.
[68] B. Dick,et al. [Drug hydroxylation disorders (debrisoquin type) in a random sample of the Swiss population]. , 1982, Schweizerische medizinische Wochenschrift.
[69] F. Jiménez-Jiménez,et al. Risk‐factors for Parkinson's disease: case‐control study in the province of Cáceres, Spain , 1994, Acta neurologica Scandinavica.
[70] M. Felgueiras,et al. The prevalence of Parkinson's disease in Portugal , 1994, European Journal of Epidemiology.
[71] I. Kondo,et al. Genetic polymorphism of paraoxonase 1 (PON1) and susceptibility to Parkinson's disease , 1998, Brain Research.
[72] C. Marsden,et al. Co-localization of P450 enzymes in the rat substantia nigra with tyrosine hydroxylase , 1998, Neuroscience.
[73] R. Krüger,et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. , 1998, Nature genetics.
[74] R. Duvoisin. Cholinergic-anticholinergic antagonism in parkinsonism. , 1967, Archives of neurology.
[75] Anthony M. Kang,et al. Global variation of a 40-bp VNTR in the 3′-untranslated region of the dopamine transporter gene (SLC6A3) , 1999, Biological Psychiatry.
[76] O. Axelson,et al. Nutritional and occupational factors influencing the risk of Parkinson's disease: A case‐control study in southeastern Sweden , 1999, Movement disorders : official journal of the Movement Disorder Society.
[77] M Behari,et al. Risk factors of Parkinson's disease in Indian patients , 2001, Journal of the Neurological Sciences.
[78] J. Goldsmith,et al. A Case-Control Study of Parkinson's Disease in Urban Population of Southern Israel , 2001, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[79] J. Somberg. Genetic polymorphisms. , 2002, American journal of therapeutics.
[80] D. Collier,et al. High and low activity alleles of catechol-O-methyltransferase gene: ethnic difference and possible association with Parkinson's disease , 1997, Neuroscience Letters.
[81] D. Collier,et al. No association between Parkinson's disease and low-activity alleles of catechol O-methyltransferase. , 1996, Biochemical and biophysical research communications.
[82] P. Amouyel,et al. S18Y polymorphism in the UCH‐L1 gene and Parkinson's disease: Evidence for an age‐dependent relationship , 2003, Movement disorders : official journal of the Movement Disorder Society.
[83] E. Teng,et al. A door-to-door survey of Parkinson's disease in a Chinese population in Kinmen. , 1996, Archives of neurology.
[84] A. Seidler,et al. Possible environmental, occupational, and other etiologic factors for Parkinson's disease , 1996, Neurology.
[85] S. Cichon,et al. Human dopamine D4 receptor gene: frequent occurrence of a null allele and observation of homozygosity. , 1994, Human molecular genetics.
[86] X Li,et al. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. , 1992, Genomics.
[87] A. Saiardi,et al. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors , 1995, Nature.
[88] J. Hubble,et al. Risk factors for Parkinson's disease , 1993, Neurology.
[89] D. Grandy,et al. The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. , 1989, American journal of human genetics.
[90] V. Uversky,et al. Pesticides directly accelerate the rate of α‐synuclein fibril formation: a possible factor in Parkinson's disease , 2001, FEBS letters.
[91] K. Jellinger,et al. Iron‐Melanin Complex in Substantia Nigra of Parkinsonian Brains: An X‐Ray Microanalysis , 1992, Journal of neurochemistry.
[92] H. Chern,et al. The COMT L allele modifies the association between MAOB polymorphism and PD in Taiwanese , 2001, Neurology.
[93] D. L. Le Couteur,et al. The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: a case-control study and meta-analysis , 1997, Journal of the Neurological Sciences.
[94] A. Lang,et al. Parkinson's disease. Second of two parts. , 1998, The New England journal of medicine.
[95] C. C. Johnson,et al. The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living , 1998, Neurology.
[96] J. Woo,et al. Lack of allelic association of dopamine D4 receptor gene polymorphisms with Parkinson's disease in a chinese population , 1999, Movement disorders : official journal of the Movement Disorder Society.
[97] K. Marder,et al. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. , 1995, American journal of epidemiology.
[98] J. Idle,et al. Allelic association between the DRD2 TaqI A polymorphism and Parkinson's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.
[99] J. Nutt,et al. Environmental antecedents of young‐onset Parkinson's disease , 1993, Neurology.
[100] Y Ben-Shlomo,et al. The epidemiology of Parkinson's disease. , 1997, Bailliere's clinical neurology.
[101] K. Leenders,et al. Hydrocarbon exposure and Parkinson’s disease , 2000, Neurology.
[102] M. L. Schmidt,et al. α-Synuclein in Lewy bodies , 1997, Nature.
[103] H. Checkoway,et al. Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease. , 1998, American journal of medical genetics.
[104] G. Morgan,et al. Poor metabolizers at the cytochrome P450 2D6 and 2C19 loci are at increased risk of developing adult acute leukaemia. , 2000, Pharmacogenetics.
[105] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[106] J. Woo,et al. The dopamine transporter gene and Parkinson's disease in a Chinese population , 1997, Neurology.
[107] J. Dartigues,et al. Association between Parkinson’s Disease and Exposure to Pesticides in Southwestern France , 2003, Neuroepidemiology.
[108] P. Tienari,et al. Apolipoprotein E (APOE), PARKIN and catechol-O-methyltransferase (COMT) genes and susceptibility to sporadic Parkinson's disease in Finland , 2002, Neuroscience Letters.
[109] J. Andersen,et al. Glutathione, iron and Parkinson's disease. , 2002, Biochemical pharmacology.
[110] J. Woo,et al. Comparison of Environmental and Genetic Factors for Parkinson’s Disease between Chinese and Caucasians , 2004, Neuroepidemiology.
[111] B. Summers,et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease , 1992, The Lancet.
[112] Y. Teo,et al. Alpha-synuclein haplotypes implicated in risk of Parkinson’s disease , 2004, Neurology.
[113] Y. M. Shi,et al. Parkinson's disease in China. Coordinational Group of Neuroepidemiology, PLA. , 1991, Chinese medical journal.
[114] D. Krikovszky,et al. Altered Distribution of the Debrisoquine Oxidative Phenotypes in Children with Type 1 Diabetes mellitus , 2004, Hormone Research in Paediatrics.
[115] H. Checkoway,et al. Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism , 2000, Journal of neurology, neurosurgery, and psychiatry.
[116] F. Jiménez-Jiménez,et al. Slow allotypic variants of the NAT2 gene and susceptibility to early-onset Parkinson's disease , 1998, Neurology.
[117] U. Rinne,et al. EPIDEMIOLOGY of PARKINSON'S DISEASE IN FINLAND , 1976, Acta neurologica Scandinavica.
[118] Jeffrey H. Kordower,et al. The role of α-synuclein in Parkinson's disease: insights from animal models , 2003, Nature Reviews Neuroscience.
[119] B. Liu,et al. Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. , 2003, Environmental health perspectives.
[120] Jeffrey H Kordower,et al. The role of alpha-synuclein in Parkinson's disease: insights from animal models. , 2003, Nature reviews. Neuroscience.
[121] S. Fahn,et al. The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it , 1992, Annals of neurology.
[122] I. Kondo,et al. Genetic association between cytochrome P450IA1 gene and susceptibility to Parkinson's disease , 2005, Journal of Neural Transmission.
[123] D. Grandy,et al. Detection and characterization of additional DNA polymorphisms in the dopamine D2 receptor gene. , 1991, Genomics.
[124] K K Kidd,et al. A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. , 1993, Human molecular genetics.
[125] D. Collier,et al. The –141C Ins/Del polymorphism of the dopamine D2 receptor gene is not associated with either migraine or Parkinson's disease , 2001, Psychiatric genetics.
[126] A. Singleton,et al. Paraoxonase 1 (PON1) gene polymorphisms and Parkinson’s disease in a Finnish population , 2004, Neuroscience Letters.
[127] S. Gruber,et al. The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients. , 1991 .
[128] W. Koller,et al. Environmental risk factors in siblings with Parkinson's disease. , 1991, Archives of neurology.
[129] J. Idle,et al. Mutant debrisoquine hydroxylation genes in Parkinson's disease , 1992, The Lancet.
[130] D. Maraganore,et al. Tyrosine hydroxylase polymorphism in familial and sporadic Parkinson's disease , 1994, Movement disorders : official journal of the Movement Disorder Society.
[131] Toshiaki Tanaka,et al. Growth Hormone Treatment in Short Japanese Children Born Small for Gestational Age , 2004, Hormone Research in Paediatrics.
[132] M. Roy,et al. Facteurs environnementaux dans l'étiologie de la maladie de Parkinson , 1990, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[133] C. Hertzman,et al. A case‐control study of Parkinson's disease in a horticultural region of British Columbia , 1994, Movement disorders : official journal of the Movement Disorder Society.
[134] S. Khuder,et al. Environmental risk factors and Parkinson's disease: a metaanalysis. , 2001, Environmental research.
[135] W. T. Hung,et al. Lack of association between CYP1A1 polymorphism and Parkinson's disease in a Chinese population , 2002, Journal of Neural Transmission.
[136] J. Kurth,et al. Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease. , 1993, American journal of medical genetics.
[137] Hagai Bergman,et al. Identifying subtle interrelated changes in functional gene categories using continuous measures of gene expression , 2005, Bioinform..
[138] C. Tanner,et al. CYP2D6 allelic frequencies in young-onset Parkinson's disease , 1996, Neurology.
[139] E. Lee,et al. Evidence for the polymorphic oxidation of debrisoquine in the Thai population. , 1990, British journal of clinical pharmacology.
[140] F. Jiménez-Jiménez,et al. Exposure to well water and pesticides in Parkinson's disease: A case‐control study in the madrid area , 1992, Movement disorders : official journal of the Movement Disorder Society.
[141] J. De Pedro-Cuesta,et al. Prevalence of Parkinson's disease in lower Aragon, Spain , 1999, Movement disorders : official journal of the Movement Disorder Society.
[142] D. L. Le Couteur,et al. Association of a polymorphism in the dopamine‐transporter gene with parkinson's disease , 1997, Movement disorders : official journal of the Movement Disorder Society.
[143] A. Barbeau. The pathogenesis of Parkinson's disease: a new hypothesis. , 1962, Canadian Medical Association journal.
[144] A. L. Werneck,et al. Genetics, drugs and environmental factors in Parkinson's disease. A case-control study. , 1999, Arquivos de neuro-psiquiatria.
[145] D. Ramsden,et al. An allelic association study of monoamine oxidase B in parkinson's disease , 1995, Annals of neurology.
[146] P. Silburn,et al. The monoamine oxidase B gene GT repeat polymorphism and Parkinson’s disease in a Chinese population , 2000, Journal of Neurology.
[147] S. Ho,et al. Epidemiologic study of Parkinson's disease in Hong Kong , 1989, Neurology.
[148] K. Honda,et al. Detection and analysis of four polymorphic markers at the human monoamine oxidase (MAO) gene in Japanese controls and patients with Parkinson's disease. , 1998, Biochemical and biophysical research communications.
[149] I. Milanov,et al. Prevalence of Parkinson’s Disease in Bulgaria , 2001, Neuroepidemiology.
[150] O. Livnah,et al. Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities , 2005, Journal of neurochemistry.
[151] C. Tanner,et al. Environmental Factors in the Etiology of Parkinson's Disease , 1987, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[152] M. P. Turpin,et al. Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system. , 1996, Biochemical and biophysical research communications.
[153] T. Riise,et al. The epidemiology of Parkinson's disease in the county of Rogaland, Norway , 1995, Movement disorders : official journal of the Movement Disorder Society.
[154] M. Rundle,et al. Association of variations in monoamine oxidases A and B with Parkinson's disease subgroups. , 2004, Genomics.
[155] K. Kawajiri,et al. Genetic Polymorphisms in the 5 '-Flanking Region Change Transcriptional Regulation of the Human Cytochrome P 45011 E 1 Gene ' , 2008 .
[156] Ichiro Kanazawa,et al. Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms , 2002, Annals of neurology.
[157] M. Hernán,et al. MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD , 2002, Neurology.
[158] S. Kikuchi,et al. Prevalence of Parkinson's disease in Hokkaido, the northernmost island of Japan. , 1996, Internal medicine.
[159] D. Maraganore,et al. Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease , 2005, Neuroscience Letters.
[160] T. Sherer,et al. Environment, Mitochondria, and Parkinson's Disease , 2002, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[161] N. Hattori,et al. Catechol-O-methyltransferase genotype and susceptibility to Parkinson's disease in Japan , 2005, Journal of Neural Transmission.
[162] G. Jarvik,et al. Paraoxonase 1 promoter and coding region polymorphisms in Parkinson’s disease , 2003, Journal of neurology, neurosurgery, and psychiatry.
[163] R. Fukuda,et al. No allelic association between Parkinson's disease and dopamine D2, D3, and D4 receptor gene polymorphisms. , 1994, American journal of medical genetics.
[164] R. Mahley,et al. Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond. , 1999, Current opinion in lipidology.
[165] C D Marsden,et al. Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease , 1997, Neurology.
[166] P. Fender,et al. [Prevalence of thirty long term disorders for French health insurance members in 1994]. , 1997, Revue d'epidemiologie et de sante publique.
[167] R. Barker,et al. The heterogeneity of idiopathic Parkinson's disease , 2002, Journal of Neurology.
[168] Marguerite Wieler,et al. Treatment of Parkinson's Disease , 2003, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[169] L. Svenson,et al. Geographic Variations in the Prevalence Rates of Parkinson’s Disease in Alberta , 1993, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[170] J R Goldsmith,et al. A Case-Referent Study of Extrapyramidal Signs (Preparkinsonism) in Rural Communities of Israel , 1998, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[171] C. Tanner,et al. Environmental factors and Parkinson's disease , 1989, Neurology.
[172] A. Blackburn,et al. Parkinson's disease, pesticides, and glutathione transferase polymorphisms , 1998, The Lancet.
[173] J. Trojanowski,et al. Polymorphisms of dopamine receptor and transporter genes and Parkinson's disease , 1995, Journal of neural transmission. Parkinson's disease and dementia section.
[174] J. Jankovic,et al. Polymorphism of NACP-Rep1 in Parkinson’s disease: An etiologic link with essential tremor? , 2000, Neurology.
[175] J. A. Dani,et al. Muscarinic and Nicotinic Cholinergic Mechanisms in the Mesostriatal Dopamine Systems , 2003, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[176] A. Persad,et al. Parkinson’s Disease and CYP2D6 Polymorphism in Asian Populations: A Meta-Analysis , 2003, Neuroepidemiology.
[177] M. Farrer,et al. Case‐Control study of dopamine transporter‐1, monoamine oxidase‐B, and catechol‐O‐methyl transferase polymorphisms in Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.
[178] A. Smargiassi,et al. A case-control study of occupational and environmental risk factors for Parkinson's disease in the Emilia-Romagna region of Italy. , 1998, Neurotoxicology.
[179] D. S. Rath,et al. Tetranucleotide repeat polymorphism at the human tyrosine hydroxylase gene (TH). , 1991, Nucleic acids research.
[180] M. Brin,et al. Anticholinergic therapies in the treatment of Parkinson's disease , 2002 .
[181] Yi Zhao,et al. Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.
[182] R. Branch,et al. Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations , 1985, Clinical pharmacology and therapeutics.
[183] J. Kurth,et al. Association of a monoamine oxidase B allele with Parkinson's disease , 1993, Annals of neurology.
[184] W. Rocca,et al. Prevalence of Parkinson's disease in junín, Buenos Aires province, argentina , 1997, Movement disorders : official journal of the Movement Disorder Society.
[185] B. Schoenberg,et al. A prevalence survey of Parkinson's disease and other movement disorders in the People's Republic of China. , 1985, Archives of neurology.
[186] S. Mandel,et al. Green tea polyphenol (–)‐epigallocatechin‐3‐gallate prevents N‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced dopaminergic neurodegeneration , 2001, Journal of neurochemistry.
[187] J. Gorell,et al. Environmental Risk Factors for Parkinson's Disease , 2003 .
[188] L. Golbe,et al. Follow‐up study of early‐life protective and risk factors in Parkinson's disease , 1990, Movement disorders : official journal of the Movement Disorder Society.
[189] W. T. Hung,et al. Strong association between N-acetyltransferase 2 genotype and PD in Hong Kong Chinese , 2003, Neurology.
[190] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[191] P. Silburn,et al. The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson's disease , 2000, Neuroscience Letters.
[192] D. Kömpf,et al. Epidemiology and out-patient care in Parkinson's disease--results from a pilot-study in northern Germany (Schleswig-Holstein). , 1991, Journal of neural transmission. Supplementum.
[193] M. Nöthen,et al. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers , 1999, Molecular Psychiatry.
[194] D. Hernandez,et al. alpha-Synuclein gene haplotypes are associated with Parkinson's disease. , 2001, Human molecular genetics.
[195] W. Dauer,et al. Parkinson's Disease Mechanisms and Models , 2003, Neuron.
[196] C. Hertzman,et al. Parkinson's disease: a case-control study of occupational and environmental risk factors. , 1990, American journal of industrial medicine.
[197] G. Defazio,et al. Epidemiology of primary blepharospasm , 2002, Movement disorders : official journal of the Movement Disorder Society.
[198] Matthew J. Farrer,et al. α-synuclein gene haplotypes are associated with Parkinson’s disease , 2001 .
[199] R. Ebstein,et al. Acetylcholinesterase/paraoxonase interactions increase the risk of insecticide‐induced Parkinson's disease , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[200] H. Helenius,et al. Environmental risk factors in Parkinson's disease , 1999, Movement disorders : official journal of the Movement Disorder Society.
[201] F. Aboitiz,et al. Does bigger mean better? Evolutionary determinants of brain size and structure. , 1996, Brain, behavior and evolution.
[202] J. Satoh,et al. A polymorphic variation of serine to tyrosine at codon 18 in the ubiquitin C-terminal hydrolase-L1 gene is associated with a reduced risk of sporadic Parkinson's disease in a Japanese population , 2001, Journal of the Neurological Sciences.
[203] R. Scheller,et al. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[204] G. Campanella,et al. [Environmental factors in the etiology of Parkinson's disease]. , 1990, The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques.